Cargando…
Strength of functional signature correlates with effect size in autism
BACKGROUND: Disagreements over genetic signatures associated with disease have been particularly prominent in the field of psychiatric genetics, creating a sharp divide between disease burdens attributed to common and rare variation, with study designs independently targeting each. Meta-analysis wit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501949/ https://www.ncbi.nlm.nih.gov/pubmed/28687074 http://dx.doi.org/10.1186/s13073-017-0455-8 |
_version_ | 1783248882466029568 |
---|---|
author | Ballouz, Sara Gillis, Jesse |
author_facet | Ballouz, Sara Gillis, Jesse |
author_sort | Ballouz, Sara |
collection | PubMed |
description | BACKGROUND: Disagreements over genetic signatures associated with disease have been particularly prominent in the field of psychiatric genetics, creating a sharp divide between disease burdens attributed to common and rare variation, with study designs independently targeting each. Meta-analysis within each of these study designs is routine, whether using raw data or summary statistics, but combining results across study designs is atypical. However, tests of functional convergence are used across all study designs, where candidate gene sets are assessed for overlaps with previously known properties. This suggests one possible avenue for combining not study data, but the functional conclusions that they reach. METHOD: In this work, we test for functional convergence in autism spectrum disorder (ASD) across different study types, and specifically whether the degree to which a gene is implicated in autism is correlated with the degree to which it drives functional convergence. Because different study designs are distinguishable by their differences in effect size, this also provides a unified means of incorporating the impact of study design into the analysis of convergence. RESULTS: We detected remarkably significant positive trends in aggregate (p < 2.2e-16) with 14 individually significant properties (false discovery rate <0.01), many in areas researchers have targeted based on different reasoning, such as the fragile X mental retardation protein (FMRP) interactor enrichment (false discovery rate 0.003). We are also able to detect novel technical effects and we see that network enrichment from protein–protein interaction data is heavily confounded with study design, arising readily in control data. CONCLUSIONS: We see a convergent functional signal for a subset of known and novel functions in ASD from all sources of genetic variation. Meta-analytic approaches explicitly accounting for different study designs can be adapted to other diseases to discover novel functional associations and increase statistical power. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13073-017-0455-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5501949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55019492017-07-10 Strength of functional signature correlates with effect size in autism Ballouz, Sara Gillis, Jesse Genome Med Research BACKGROUND: Disagreements over genetic signatures associated with disease have been particularly prominent in the field of psychiatric genetics, creating a sharp divide between disease burdens attributed to common and rare variation, with study designs independently targeting each. Meta-analysis within each of these study designs is routine, whether using raw data or summary statistics, but combining results across study designs is atypical. However, tests of functional convergence are used across all study designs, where candidate gene sets are assessed for overlaps with previously known properties. This suggests one possible avenue for combining not study data, but the functional conclusions that they reach. METHOD: In this work, we test for functional convergence in autism spectrum disorder (ASD) across different study types, and specifically whether the degree to which a gene is implicated in autism is correlated with the degree to which it drives functional convergence. Because different study designs are distinguishable by their differences in effect size, this also provides a unified means of incorporating the impact of study design into the analysis of convergence. RESULTS: We detected remarkably significant positive trends in aggregate (p < 2.2e-16) with 14 individually significant properties (false discovery rate <0.01), many in areas researchers have targeted based on different reasoning, such as the fragile X mental retardation protein (FMRP) interactor enrichment (false discovery rate 0.003). We are also able to detect novel technical effects and we see that network enrichment from protein–protein interaction data is heavily confounded with study design, arising readily in control data. CONCLUSIONS: We see a convergent functional signal for a subset of known and novel functions in ASD from all sources of genetic variation. Meta-analytic approaches explicitly accounting for different study designs can be adapted to other diseases to discover novel functional associations and increase statistical power. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13073-017-0455-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-07 /pmc/articles/PMC5501949/ /pubmed/28687074 http://dx.doi.org/10.1186/s13073-017-0455-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Ballouz, Sara Gillis, Jesse Strength of functional signature correlates with effect size in autism |
title | Strength of functional signature correlates with effect size in autism |
title_full | Strength of functional signature correlates with effect size in autism |
title_fullStr | Strength of functional signature correlates with effect size in autism |
title_full_unstemmed | Strength of functional signature correlates with effect size in autism |
title_short | Strength of functional signature correlates with effect size in autism |
title_sort | strength of functional signature correlates with effect size in autism |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501949/ https://www.ncbi.nlm.nih.gov/pubmed/28687074 http://dx.doi.org/10.1186/s13073-017-0455-8 |
work_keys_str_mv | AT ballouzsara strengthoffunctionalsignaturecorrelateswitheffectsizeinautism AT gillisjesse strengthoffunctionalsignaturecorrelateswitheffectsizeinautism |